secwatch.observer — SEC 8-K summary
======================================

Issuer:     IR-Med, Inc. (—)
CIK:        0001839133
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001493152-23-018910
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Moshe Gerber resigns; Chairperson Oded Bashan named Interim CEO
-------------------------------------------------------------------

- Moshe Gerber resigned as CEO of IR-Med, Inc. and its Israeli subsidiary, effective May 21, 2023.
- Resignation is not due to any disagreement with the company or its auditors.
- Gerber will remain available until August 19, 2023, receiving salary and benefits through August.
- Accelerated vesting of 433,333 stock options at $0.32/share, exercisable through Dec 31, 2030.
- Upon compliance, Gerber receives an additional 21,000 NIS (~$5,780) at end of notice period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer